Antibody variable region engineering for improving cancer immunotherapy-Reference-Cited by-同舟云学术

Antibody variable region engineering for improving cancer immunotherapy

Published:2022-07-13 Issue:9 Volume:42 Page:804-827
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Lou Hantao¹²,Cao Xuetao²³

Affiliation:

1. Ludwig Institute of Cancer Research University of Oxford Oxford OX3 7DR UK

2. Chinese Academy for Medical Sciences Oxford Institute Nuffield Department of Medicine University of Oxford Oxford OX3 7FZ UK

3. Department of Immunology Centre for Immunotherapy, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences Beijing 100005 P. R. China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12330

Reference206 articles.

1. The birth of monoclonal antibodies

2. Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma

3. Caplacizumab: First Global Approval

4. FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease

5. Advancing to the era of cancer immunotherapy

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of single-chain variable fragments and monoclonal antibody against dihydroartemisinin;Journal of Immunological Methods;2024-09

2. Designing Robust Monoclonal Antibody Drug Products: Pitfalls of Simplistic Approaches for Stability Prediction;Journal of Pharmaceutical Sciences;2024-08

3. Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy;Acta Pharmaceutica Sinica B;2024-08

4. Precision engineering of antibodies: A review of modification and design in the Fab region;International Journal of Biological Macromolecules;2024-08

5. Modified heated CGMD simulations for discovering stable docked conformations of BiTE antibody against CD3 and CD117/c-kit;Molecular Simulation;2024-07-24